My ATP7B Genetic Test Came Back \"Uncertain\" — What Does That Mean?

Getting a genetic test result that says “variant of uncertain significance” — or VUS — is one of the most frustrating things that can happen during a Wilson disease work-up. You went looking for an answer, and the result handed you a question mark instead. Here is what that label actually means, why it happens so often with the ATP7B gene, and what your medical team will likely do next.

What “variant of uncertain significance” actually means

Every person’s DNA differs from a reference sequence at millions of points. Most of those differences are harmless. A few cause disease. A VUS sits in the middle: the lab found a change in your ATP7B gene, but the available scientific evidence is not yet strong enough to say with confidence that the change disrupts copper transport and causes Wilson disease — or that it is completely innocent.¹

The classification is not a permanent verdict. Laboratories apply a standardized five-tier system (pathogenic → likely pathogenic → uncertain significance → likely benign → benign) developed by the American College of Medical Genetics and Genomics. VUS is the center category, and reclassification happens regularly as more data accumulate.² Studies of large epilepsy and cardiology cohorts suggest that a meaningful fraction of VUS results — sometimes over a third — are reclassified within a few years, nearly always toward benign or likely benign.³

Why ATP7B is particularly prone to VUS results

The ATP7B gene is large and remarkably variable. Over 900 disease-causing variants have been reported worldwide, but they are not evenly distributed: some are common in specific ethnic populations while others appear in only a handful of families ever.⁴ This diversity creates a practical problem for labs: when a variant has been seen only once or twice in the literature, there is simply not enough evidence to classify it. The result goes into the VUS pile — not because it is probably harmless, but because the data required for a confident call do not yet exist.

A 2020 analysis in Human Genetics showed that ATP7B variant penetrance (how often a given mutation actually causes disease) varies widely depending on which variant is present and on the second copy of the gene.⁵ That variability means the same VUS in two different people — one of whom has a clearly pathogenic variant on the other chromosome, and one of whom does not — can carry very different clinical implications.

What happens when a VUS is found alongside your clinical picture

A VUS alone does not make or rule out a Wilson disease diagnosis. Your specialist will look at the VUS in the context of your full picture:⁶

Piece of evidence	What it adds
Second ATP7B variant on the other chromosome	Strengthens suspicion; two variants (compound heterozygosity) is the typical pattern in Wilson disease
Kayser-Fleischer rings on slit-lamp exam	Strong positive sign — rarely present in any other condition
Ceruloplasmin level	Low ceruloplasmin is suggestive but not diagnostic on its own
24-hour urine copper	Elevated excretion supports the diagnosis
Liver biopsy copper quantification	Elevated hepatic copper (usually well above the diagnostic threshold) is the most direct tissue evidence
Family history of confirmed Wilson disease	Substantially raises pre-test probability

The 2022 AASLD Practice Guidance from Schilsky emphasizes that genetic testing is most powerful when it confirms what clinical tests already suggest, and that ambiguous genetic results should always be interpreted alongside biochemical and histological findings rather than in isolation.⁶

What your team will do next

Functional testing of the variant. Some research laboratories can test whether the specific amino acid change your VUS introduces actually impairs the protein’s ability to pump copper. A 2019 preprint demonstrated thermodynamic destabilization as one method to assess ATP7B VUS pathogenicity.⁷ This kind of functional evidence can accelerate reclassification, though it is not yet routine clinical practice everywhere.

Segregation analysis. If your family members are willing to be tested, finding the same variant only in relatives who have confirmed disease (and not in healthy relatives) is strong evidence the variant is pathogenic. Conversely, finding it in many healthy relatives points toward benign. Your genetic counselor can help coordinate this.

Second variant search. Most people with Wilson disease carry two disease-causing ATP7B variants — one inherited from each parent. If only one was reported, the lab may have missed the second, especially if it lies outside the regions routinely sequenced. Comprehensive sequencing or deletion/duplication analysis can sometimes find it.

Watchful monitoring. When the VUS cannot be resolved quickly, your team will usually treat you as a suspected case and watch for clinical or biochemical signs while tests continue. This is not neglect — it is appropriate management of diagnostic uncertainty.

Registries and reclassification: how the answer may come over time

Laboratories are required to revisit VUS classifications as new evidence emerges, and many proactively re-contact patients when a reclassification occurs. Enrolling in a Wilson disease patient registry — several exist through academic hepatology centers and patient organizations — can contribute to the evidence base that eventually resolves your specific variant. It is also worth asking your lab to share your case with ClinVar, the public variant database where classified ATP7B variants are pooled, because a single submitted case can sometimes tip the evidence scale.

What this means practically for you right now

A VUS does not put you in diagnostic limbo forever. It means your team needs more information, and most of the time, that information is obtainable. If your clinical picture — symptoms, copper tests, liver findings — is worrying, a liver biopsy may give a definitive answer even while the genetic picture remains uncertain. If your clinical tests are all reassuring and the VUS was found incidentally, the most likely outcome is that the variant will eventually be reclassified as benign.

The key is to stay connected with a specialist who has experience with Wilson disease rather than waiting passively. Reclassification can happen at any time, and the methods for assessing variant pathogenicity are improving steadily.⁸

For more context on how Wilson disease is usually confirmed, see how Wilson disease is diagnosed and what to tell your doctor at the next appointment.

This page is for general patient education and does not substitute for advice from your own physician or genetic counselor. Diagnostic decisions about VUS results depend on your individual clinical picture and should be made with your specialist.

References